standard testing procedure cyanocobalamin
Storage Requirements:
Store protected from light and moisture.
Sampling:
Sample equal quantity from each container / bag. Collect a minimum of 1g from each container/bag sample into individual,
self –sealing clear polythene bag kept in another clear self sealing polythene bag bearing ‘Sample for Analysis lable.
After completion of sampling return rest sample on same container. Collect control sample in Pet Bottle/Glass Bottle.
Quantity of Composite Sample:
1.0g
Quantity of individual Identification
0.0100 g from each and every container /bag.
Quantity of Control Sample:
2 X 1.0 g
Description: A dark red, crystalline powder; very hygroscopic.
Solubility: Sparingly soluble in water and in ethanol (95 per cent); practically insoluble in chloroform, in acetone and in ether.
Identification:
A. By UV: The ratio of the absorbance at about 361 nm to that at about 278 nm is 1.70 to 1.90
B. By TLC: The principal spot in the chromatogram obtained with the test solution corresponds to that in the
chromatogram obtained with the reference solution.
C. By chemically: a blue colour is formed and is taken into the benzyl alcohol layer.
Related substances (Determine by liquid chromatography):
In the chromatogram obtained with the test solution the sum of the areas of any secondary peaks is not greater than the area of
the principal peak in the chromatogram obtained with reference solution (a). Ignore any peak the area of which is less than that of the principal peak in the chromatogram obtained with reference solution (b). The test is not valid unless the chromatogram obtained with reference solution (c) exhibits two principal peaks, the resolution between these peaks is 2.5 or more and the chromatogram obtained with reference solution (a) exhibits one principal peak.
Loss on drying: Not more than 12.0 % w/w, determined on 20.0 mg by drying in an oven at 105° at a pressure of 1.5 to 2.5 kPa for 2 hours.
Assay: Between 96.0% to 102.0%w/w on the dried basis.
Description: A dark red, crystalline powder; very hygroscopic.
Procedure: Take the sample and spread in petridish and examine the substance by visually.
Reporting: Report as Complies / does not complies.
Solubility: Sparingly soluble in water and in ethanol (95 per cent); practically insoluble in chloroform, in acetone and in ether. Perform test as per sop
Reporting: Report as Complies/Does not comply.
Identification:
A. By UV: When examined in the range 260 nm to 610 nm, a 0.0025 % w/v solution shows absorption maxima, at about 278 nm, 361 nm and 547 nm to 559 nm.
The ratio of the absorbance at about 361 rim to that at about 547nm to 559 nm is 3.15 to 3.45 and the ratio of the absorbance
at about 361 nm to that at about 278 nm is 1.70 to 1.90.
Reporting: Report as in value.
B. By TLC: Determine by thin-layer chromatography, protected from light and coating the plate with silica gel G.
Mobile phase: A mixture of 60 volumes of chloroform, 40 volumes of methanol and 12 volumes of 6 M ammonia. Use an unlined tank.
Test solution: Dissolve 20 mg of the substance under examination in 10 ml of ethanol (50 per cent).
Reference solution: A 0.2 per cent w/v solution of Cyanocobalamin RS in ethanol (50 per cent).
Apply to the plate 10µl of each solution. Allow the mobile phase to rise 12 cm. Dry the plate in air and examine in day light. The principal spot in
the chromatogram obtained with the test solution corresponds to that in the chromatogram obtained with the reference solution.
Reporting: Report as Complies/Does not comply.
C. By chemically: Mix about 1 mg with 10 mg of potassium sulphate and 0.1 ml of 0.5 M sulphuric acid and heat carefully to redness.
Allow to cool, add to the residue 0.1 ml of water, 0.5 ml of saturated solution of ammonium thiocyanate and 0.5 ml of benzyl alcohol and shake;
a blue colour is formed and is taken into the benzyl alcohol layer.
Reporting: Report as Complies/Does not comply.
Related substances (Determine by liquid chromatography):
The following solutions should be used within 1 hour of preparation.
Test solution: Dissolve 10 mg of the substance under examination in 10 ml of the mobile phase.
Reference solution (a): A 0.003 % w/v solution of the substance under examination in the mobile phase.
Reference solution (b): A 0.0001 % w/v solution of the substance under examination in the mobile phase.
Reference solution (c): Dissolve 5 mg of the substance under examination in 2 ml of water, warming if necessary, allow to cool, add 1 ml
of a 0.1 % w/v solution of chloramine T and 0.1 ml of 0.05 M hydrochloric acid, dilute to 5 ml with water, shake and allow to stand
for 5 minutes. Dilute 1 ml of this solution to 10 ml with the mobile phase use immediately.
Chromatographic system:
– A stainless steel column 25 cm x 4 mm, packed with octylsilane bonded to porous silica (5 µm),
– Mobile phase: a mixture of 147 volumes of a 1.0 % w/v solution of disodium hydrogen phosphate and 53 volumes of methanol
adjusted to pH 3.5 with phosphoric acid (to be used within 2 days of preparation),
– Flow rate. 0.8 ml per minute,
– Spectrophotometer set at 361 nm,
– Injection volume. 20 µl.
Inject the test solution and reference solutions (a), (b) and (c). Allow the chromatography to proceed for three times
the retention time of the peak due to cyanocobalamin.
In the chromatogram obtained with the test solution the sum of the areas of any secondary peaks is not greater than
the area of the principal peak in the chromatogram obtained with reference solution (a). Ignore any peak
the area of which is less than that of the principal peak in the chromatogram obtained with reference solution (b).
The test is not valid unless the chromatogram obtained with reference solution (c) exhibits two principal peaks,
the resolution between these peaks is 2.5 or more and the chromatogram obtained with reference solution (a) exhibits one principal peak.
Reporting: Report as Complies/Does not comply.
Loss on drying: Not more than 12.0 % w/w, determined on 20.0 mg by drying in an oven at 105° at a pressure of 1.5 to 2.5 kPa for 2 hours.
Reporting: Report in %w/w.
Assay:
Weigh accurately about 25 mg and dissolve in sufficient water to produce 1000.0 ml.
Measure the absorbance of the solution at the maximum at about 361 nm.
Calculate the content of C63H88CoN14O14P, taking 207as the specific absorbance at 361 nm.
Reporting: Reporting as per %.
Analysis of vitamin B1 B6 B2 Nicotinamide and sodium pentothenate Injection
Analysis for Nandrolone Decanoate injection
Analysis of Dicyclomine and Diclofenac sodium Injection
standard testing procedure of Fexofenadine and Phenylephrine suspension
standard testing procedure of Piroxicam Injection
STP of Fungal Diastase and Papain capsules
standard testing procedure PVC
standard testing procedure glass ampoule
Standard testing procedure of Iron Sucrose Injection
Standard testing procedure lactose
Standard testing procedure mefenamic acid
standard testing procedure domperidone
standard testing procedure flavour mixed fruit
standard testing procedure dicyclomine hydrochloride
Standard testing procedure honey pure
standard testing procedure dextromethorphan hydrobromide
standard procedure of levocarnitine injection
Analysis of Ivermectin Suspension
standard testing procedure artemether injection
standard testing procedure artemether injection
standard testing procedure Carbocisteine syrup
standard testing procedure Phytomenadione injection
standard testing procedure serratiopeptidase
standard testing procedure starch IP
standard testing procedure sucrose refined sugar
standard testing procedure titanium dioxide
standard testing procedure tramadol hydrochloride
standard testing procedure zinc sulphate
standard testing procedure croscarmellose sodium
standard testing procedure colour erythrosine supra
standard testing procedure magnesium hydroxide
standard testing procedure diclofenac sodium
standard testing procedure dibasic calcium phosphate
standard testing procedure cyanocobalamin
standard testing procedure cholecalciferol
standard testing procedure Calcium carbonate oyster shell powder
standard test procedure Calcium Citrate
standard testing procedure Bronopol
standard testing procedure Bromhexine Hydrochloride
Standard Testing Procedure diclofenac sodium injection
Standard Testing Procedure Drotaverine Hydrochloride injection
Standard Testing Procedure Tranexamic acid injection
standard test procedure paracetamol infusion
standard test procedure ofloxacin and ornidazole infusion
standard test procedure ornidazole injection
standard test procedure Ondansetron injection
standard test procedure dextrose injection
standard test procedure ciprofloxacin injection
STP and analysis method of Ammonium Chloride
Analysis method of aceclofenac
analysis method of Losartan Potassium and Hydrochlorothiazide
analysis method of Linezolid Dry Syrup
analysis method of Drotaverine Hydrochloride and Mefenamic acid
Analysis method of Ceftriaxone Sodium and Sulbactam sodium Injection
analysis method of Cefepime and Tazobactam Injection
Analysis method of Hydroquinone Cream
Analysis method of Tacrolimus Ointment
Analysis method of Terbinafine HCL Cream
Analysis method of Mometasone Furoate and Fusidic Acid Cream
Analysis method of Disodium Hydrogen Citrate Syrup
Analysis method of Hydroquinone with Tretinoin Cream
Analysis method of Hydroquinone Tretinoin and Mometasone Furoate Cream
Analysis method of Sertaconazole Nitrate Cream
Analysis method of Halobetasol Propionate Cream
Analysis method of Povidone Iodine with Ornidazole Ointment
Analysis method of Eberconazole Cream
Analysis method of Luliconazole Cream
Analysis method of Fluconazole Gel
Analysis method of Ketoconazole Cream
Analysis method of Salbutamol and Choline theophyllinate Syrup
Analysis method of Methylcobalamin Injection
Analysis method of Piroxicam and paracetamol Injection
Analysis method of Alpha Beta Arteether Injection
Analysis method of Enrofloxacin Suspension
Analysis method of Levetiracetam Syrup
Analysis method of Sucralfate suspension
Analysis method of Sucralfate and Oxetacaine Suspension
Analysis method of Quinine Sulphate Suspension
Analysis method of Calcium Carbonate vitamin D3 Zinc Gluconate and Magnesium hydroxide suspension
Analysis method of Suspension of Tribasic Calcium phosphate with vitamin D3 and Vitamin B12
Analysis method of Calcitriol with calcium citrate Suspension
Analysis method of Oxyclozanide and Fenbendazole Suspension
Analysis method of Oxyclozanide and Levamisole Suspension
Analysis method of Triclabendazole and Ivermectin Suspension
Analysis method of Itraconazole Solution
Analysis method of Levocetirizine Dihydrochloride syrup
Analysis method of Iron Calcium Vitamin D3 Folic Acid Vitamin B12 Suspension
Analysis method of Ferrous Ascorbate Cyanocobalamin and Folic Acid Suspension
Analysis method of Ambroxol Hydrochloride Drops
Analysis method of Ferrous Ascorbate with Folic Acid suspension
Analysis method of Piracetam Syrup
Analysis method of Rafoxanide and Levamisole suspension
Analysis method of Zinc gluconate Syrup
Analysis method of Magaldrate Simethicone and Oxetacaine suspension
Analysis method of mefenamic acid and paracetamol suspension
Analysis method of Cholecalciferol Drops
Analysis method of Racecadotril suspension
Analysis method of Deflazacort Suspension
Analysis method of Montelukast sodium and levocetirizine Dihydrochloride Syrup
Analysis method of Iron and Folic Acid Syrup
Analysis method of Cyproheptadine Hydrochloride and Tricholine Citrate Syrup
Analysis method of Levofloxacin Hemihydrate Ornidazole and Vitamin E Solution
Analysis method of Albendazole and ivermectin in oral liquid